# Exosomal crosstalk: the metastatic language of hepatocellular carcinoma

## TL;DR

This review explores how exosomes influence liver cancer progression and their potential for diagnosis and treatment.

## Contribution

The paper highlights exosomes' dual role in HCC and identifies research priorities for clinical translation.

## Key findings

- Exosomes promote tumor progression and metastasis in hepatocellular carcinoma.
- Exosomes show promise as diagnostic biomarkers and therapeutic delivery vehicles.
- Further research is needed to understand exosome mechanisms and clinical applications.

## Abstract

Exosomes have garnered considerable attention in hepatocellular carcinoma (HCC) research owing to their critical function in regulating intercellular communication within the tumor microenvironment. Their inherent composition, structural integrity, and cargo-specific properties underpin critical functions in orchestrating cellular information transfer. This review delineates the fundamental biology of exosomes, their multifaceted pathophysiological roles in HCC, and the inherent translational promise of exosome-based therapeutic platforms for HCC management. Emerging evidence positions exosomes as dual-functional entities in HCC: not only propagating tumor progression and metastasis but also emerging as liquid biopsy-based diagnostic indicators for early detection and prognostic stratification, as well as nanoscale delivery platforms for site-specific therapeutic payloads. Nevertheless, despite growing recognition of exosomal functions in HCC, the precise mechanisms governing their functional duality and clinical translatability demand further elucidation. Through critical appraisal of extant literature, this review delineates actionable research priorities to catalyze mechanistic dissection and accelerate bench-to-bedside translation in exosome-based HCC management.